NBP255496PE

Novus Biologicals™ ST8 alpha-2,8-Sialyltransferase 4/ST8SIA4 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

The price for this product is unavailable. Please request a quote

Gene ID (Entrez)

7903

Common Name

ST8 alpha-2,8-Sialyltransferase 4/ST8SIA4 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

Alpha-2,8-sialyltransferase 8D, CMP-N-acetylneuraminate-poly-alpha-2,8-sialyl transferase, CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase, EC 2.4.99, EC 2.4.99.-, Polysialyltransferase-1, PST1MGC61459, PSTMGC34450, sialyltransferase 8 (alpha-2,

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

ST8SIA4

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-50263. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP256457PE

--

Img

Novus Biologicals™

NBP255364PE

--

Img

Novus Biologicals™

NBP255688PE

--

Img

Novus Biologicals™

NBP255298PE

--

Img

Novus Biologicals™

NBP255274PE

--

Img

Novus Biologicals™

NBP255916PE

--

Img

Novus Biologicals™

NBP256187PE

--

Img

Novus Biologicals™

NBP255269PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human ST8 alpha-2,8-Sialyltransferase 4/ST8SIA4
  • Source: E.coli Amino Acid Sequence: VQRAFGGFRNESDREKFVHRLSMLNDSVLWIPAFMVKGGEKHVEWVNAL The ST8 alpha-2,8-Sialyltransferase 4/ST8SIA4 Recombinant Protein Antigen is derived from E
  • coli
  • The ST8 alpha-2,8-Sialyltransferase 4/ST8SIA4 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.